Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports.
CADASIL
CGRP
NOTCH3
erenumab
migraine
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
24 Mar 2024
24 Mar 2024
Historique:
received:
11
02
2024
revised:
14
03
2024
accepted:
21
03
2024
medline:
13
4
2024
pubmed:
13
4
2024
entrez:
13
4
2024
Statut:
epublish
Résumé
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common monogenic form of cerebral small vessel disease, caused by a mutation in the
Identifiants
pubmed: 38610637
pii: jcm13071870
doi: 10.3390/jcm13071870
pii:
doi:
Types de publication
Case Reports
Langues
eng